Upgrade to SI Premium - Free Trial

Tactile Systems Technology, Inc. (TCMD) Misses Q4 EPS by 3c, Revenues Beat; Offers FY20 Revenue Guidance Above Consensus

February 26, 2020 4:10 PM

Tactile Systems Technology, Inc. (NASDAQ: TCMD) reported Q4 EPS of $0.22, $0.03 worse than the analyst estimate of $0.25. Revenue for the quarter came in at $57.1 million versus the consensus estimate of $55.52 million.

Fourth Quarter 2019 Summary:

“We are pleased to report another quarter of impressive performance, which resulted in revenue growth of 23% year-over-year,” said Gerald R. Mattys, Chief Executive Officer of Tactile Medical. “Our solid execution during the fourth quarter enabled us to bring 2019 to a strong close, with improved profitability and full year revenue growth of 32%. Our success was driven by investments in expanding our field sales team, solid market adoption of the Flexitouch Plus system, a targeting strategy focused on the most productive accounts in the lymphedema market and the broad in-network coverage we have obtained with commercial payers. As we enter 2020, we remain focused on increasing our share of the growing $5+ billion addressable U.S. market opportunity in lymphedema and chronic venous insufficiency and believe we are poised to deliver 20% or more top line growth and another year of improved profitability.”

GUIDANCE:

Tactile Systems Technology, Inc. sees FY2020 revenue of $227.5-230.5 million, versus the consensus of $224.83 million.

For earnings history and earnings-related data on Tactile Systems Technology, Inc. (TCMD) click here.

Categories

Corporate News Earnings Guidance Hot Guidance Management Comments

Next Articles